You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

North American Pharmaceutical/Biotech Industry Expects Robust Capital Construction Activity in First Half of 2020, an Industrial Info Market Brief

default

Industry Segment: Market Brief | Word Count: 73 Words
Attachment: Pharma

The Pharmaceutical & Biotech Industry outlook remains strong for the first half of 2020. Industrial Info's Pharma/Bio group is tracking nearly 360 major capital construction projects with a total investment value (TIV) of $14.4 billion set for kickoff in this time frame. The U.S. northeast region leads in expenditures, followed by the southeast and New England regions.

Subscribe Now! All Fields Required...

Standard Membership - Free